<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>7
<FILENAME>d832380dex1020.htm
<DESCRIPTION>EX-10.20
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.20</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
  
 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="86%"></TD> 
<TD VALIGN="bottom" WIDTH="2%"></TD> 
<TD WIDTH="12%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Confidential Materials omitted and filed separately with the</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Securities and Exchange Commission. Double asterisks denote omissions.</P></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="middle" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;10.20</B></P></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>THIS <B>LICENSE AGREEMENT </B>(the <B>&#147;Agreement&#148;) </B>is entered into by and between <B>THE JOHNS HOPKINS UNIVERSITY, </B>a
Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland 21218-2695 <B>(&#147;JHU&#148;) </B>and <B>TOKAI PHARMACEUTICALS, INC., </B>a Delaware corporation having an address at One Broadway, 14th Floor, Cambridge,
Massachusetts 02142 <B>(&#147;LICENSEE&#148;). </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>WHEREAS, a valuable invention or inventions listed and described in <U>Exhibit A</U> <B>(&#147;INVENTION&#148;) </B>was/were developed
during the course of research conducted by the inventors listed on <U>Exhibit A</U> (all hereinafter, <B>&#147;INVENTORS&#148;)</B>. <B>JHU </B>has acquired through assignment all rights, title and interest of said <B>INVENTORS </B>in said valuable
<B>INVENTION </B>and the related patent rights. <B>JHU </B>desires that the invention be perfected and marketed as soon as possible so that resulting products may be available for public use and benefit.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>WHEREAS, <B>LICENSEE </B>desires to obtain certain rights in such <B>INVENTIONS </B>and related patent rights and know-how as herein
provided, and to commercially develop, manufacture, use and distribute products and processes based upon or embodying said valuable inventions and/or know-how, and <B>JHU </B>desires to grant such rights to <B>LICENSEE </B>on the terms set forth
herein.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledge, the parties to this Agreement hereby agree as follows: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>DEFINITIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references to particular Exhibits, Articles or Paragraphs shall mean
the Exhibits to, and Paragraphs and Articles of, this Agreement, unless otherwise specified. Any reference herein to any defined term shall include both the singular and the plural, whether or not both forms are included in the reference. For the
purposes of this Agreement and the Exhibits hereto, the following words and phrases shall have the following meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.1
<B>&#147;AFFILIATED COMPANY&#148; </B>means any corporation, company, partnership, joint venture or other entity, which controls, is controlled by or is under common control with <B>LICENSEE</B>. For purposes of this Paragraph control shall mean the
direct or indirect ownership of at least fifty percent (50%)&nbsp;of the voting stock or other ownership interest of such entity.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.2 <B>&#147;EFFECTIVE DATE&#148; </B>means the date that the last party hereto has executed this Agreement.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.3 <B>&#147;EXCLUSIVE LICENSE&#148; </B>means that, subject to specific limitations in this Agreement, and subject to rights retained
by the United States Government, if any, <B>JHU </B>grants to <B>LICENSEE </B>all of <B>JHU&#146;s </B>rights under the <B>LICENSED PATENT(S) </B>in the <B>FIELD OF USE </B>in the <B>LICENSED TERRITORY</B>. Exclusive refers to <B>LICENSED PATENTS
</B>only. <B>KNOW HOW, </B>data and other materials licensed are provided on a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> basis only.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.4 <B>&#147;FIELD OF USE&#148; </B>has the meaning given it in <U>Exhibit A</U>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5 <B>&#147;FIRST COMMERCIAL SALE&#148; </B>means the first transfer by a <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE </B>of a <B>LICENSED
PRODUCT or LICENSED SERVICE </B>for value, but shall not include </P> 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a transfer of materials for the purpose of use in a clinical trial, where the consideration received is intended to cover the manufacturing costs of the materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.6 <B>&#147;IMPROVEMENT&#148; </B>means an invention( a) that is first conceived or reduced to practice on or after the <B>EFFECTIVE
DATE, </B>(b)&nbsp;where an <B>INVENTOR </B>is an inventor as determined under U.S. patent law, and (c)&nbsp;the use or practice of which in the <B>FIELD OF USE </B>would be dominated by one or more claims of the <B>LICENSED PATENTS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.7 <B>&#147;JHU REF. NUMBER&#148; </B>means the <B>JHU </B>Technology Transfer Office case number or numbers, shown on Exhibit A, to
which the <B>TECHNOLOGY </B>licensed pertains. It is used for <B>JHU </B>reference only. The <B>TECHNOLOGY </B>licensed herein is described in this Agreement, and may not include all the technology that may be a part of the <B>JHU </B>reference
number.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.8 <B>&#147;JHU INDEMNITEES&#148; </B>means <B>JHU, </B>The Johns Hopkins Hospital, The Johns Hopkins Health
System Corporation, and their affiliated entities, their present and former trustees, officers, <B>INVENTORS, </B>agents, faculty, employees and students.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.9 <B>&#147;KNOW HOW&#148; </B>means non-public information, including but not limited to data, test results, research methodology or
manufacturing techniques created by <B>INVENTORS </B>that is necessary or useful for the effective practice of the <B>LICENSED PATENTS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.10 <B>&#147;LICENSED PATENT&#148; </B>means (a)&nbsp;[**] and the inventions disclosed and claimed therein, (b)&nbsp;any patent or
patent application that claims priority to and is a divisional, continuation, reissue, renewal, reexamination, substitution or extension of any patent application identified in (a); (c)&nbsp;any patents issuing on any patent application identified
in (a)&nbsp;or (b), including any reissues, renewals, reexaminations, substitutions or extensions thereof; (d)&nbsp;any claim of a continuation-in-part application or patent (including any reissues, renewals, reexaminations, substitutions or
extensions thereof) that is entitled to the priority date of, and is directed specifically to subject matter specifically described in, at least one of the patents or patent applications identified in (a), (b), (c); (e)&nbsp;any foreign counterpart
(including PCTs) of any patent or patent application identified in (a), (b), or (c)&nbsp;or of the claims identified in (d); and (f)&nbsp;any supplementary protection certificates, pediatric exclusivity periods, any other patent term extensions and
exclusivity periods and the like of any patents and patent applications identified in (a)&nbsp;through (e).<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.11
<B>&#147;LICENSED PRODUCT&#148; </B>shall mean any process or method, material, compositions, drug, or other product, created or developed using <B>TECHNOLOGY, </B>or for which the development, manufacture, use or sale, if done by a third party
without rights under the <B>LICENSED PATENT(S), </B>would constitute an infringement of a <B>VALID CLAIM of LICENSED PATENTS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.12 <B>&#147;LICENSED SERVICE&#148; </B>includes any service or services, including the manufacture of any product or the use of any
product or composition, performed by <B>LICENSEE </B>for any third party using or incorporating the <B>TECHNOLOGY, </B>or which, if done by a third party without rights under the <B>LICENSED PATENT(S), </B>would constitute an infringement of a claim
of <B>LICENSED PATENTS. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.13 <B>&#147;LICENSED TERRITORY&#148; </B>means all of the countries in the world.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.14 <B>&#147;NET REVENUES&#148; </B>whether they be <B>NET SALES REVENUES OR NET SERVICE REVENUES </B>shall include everything of value
actually received by <B>LICENSEE, AFFILIATED COMPANIES </B>and </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>SUBLICENSEE(S) </B>for the sale, license, lease or other transfer of <B>LICENSED PRODUCTS, </B>or the performance of <B>LICENSED SERVICES</B>. Consideration includes but is not limited to
currency, equity of the purchaser, lessee or other transferee, intangible rights, services and other things of value provided or received as part of the transaction for <B>LICENSED PRODUCTS or LICENSED SERVICES, </B>the fair value of which must be
included to determine <B>NET REVENUES</B>. <B>NET REVENUES </B>may be calculated using the accrual or cash method, but such calculation must be consistent from month to month and year to year, and must be the same method used by <B>LICENSEE </B>for
all similar transactions, or if none, the same method used generally by <B>LICENSEE </B>in reporting its business activity for United States federal tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NET REVENUES </B>may exclude the following items, but only to the extent that they are included in gross revenue, and are separately billed
to purchaser, and paid or remitted by <B>LICENSEE </B>to third parties:<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) import, export, excise and sales taxes, custom duties,
and shipping charges; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) costs of packing, insurance covering damage during shipping, and transportation from the place of manufacture
to the customer&#146;s premises or point of installation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) amounts repaid or credited by reason of rejections, defects, errors,
overbilling, recalls or returns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>In the event that a <B>LICENSED PRODUCT or LICENSED SERVICE </B>is sold in a country or other
jurisdiction in the Territory in the form of a combination product/service, <B>NET REVENUES </B>shall be calculated by multiplying <B>NET REVENUES </B>for the combination product/service by the fraction A/(A+B), where A is the invoice price of the
<B>LICENSED PRODUCT or LICENSED SERVICE </B>and B is the invoice price of the other service(s) in the combination product/service if both the <B>LICENSED PRODUCT or LICENSED SERVICE </B>(as applicable) and the other product(s) or service(s) are sold
separately. If either the <B>LICENSED PRODUCT or LICENSED SERVICE </B>(as applicable) or the other product(s) or service(s) in the combination product/service are not sold separately, <B>NET REVENUES </B>shall be calculated by multiplying <B>NET
REVENUES </B>for the combination product/service by the fraction C/(C+D), where C is the value of the <B>LICENSED PRODUCT or LICENSED SERVICE </B>(as applicable) and D is the reasonably estimated value (using accepted industry standards) of the
other product(s) or service(s) in the combination product/service, based at least in part on the value of the other active component or components used in the combination product/service.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.15 <B>&#147;NET SALES REVENUES&#148; </B>shall mean <B>NET REVENUES </B>derived from the sale of <B>LICENSED PRODUCTS, </B>where a
sale includes any license of use, lease, sale or other transfer of rights to the <B>LICENSED PRODUCT. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.16 <B>&#147;NET
SERVICE REVENUES&#148;</B> SHALL mean <B>NET REVENUES</B> derived from the sale or performance of <B>LICENSED SERVICES</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.17 <B>&#147;PATENT COSTS&#148; </B>means all unreimbursed costs of prosecuting and maintaining any <B>LICENSED PATENT, </B>including
reasonable attorneys&#146; fees or costs paid or incurred, and expenses paid or incurred for filing, maintenance, annuities, translation, or other costs directly related to the PATENT prosecution and maintenance.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.18 <B>&#147;SUBLICENSEE&#148; </B>means any person or entity other than an <B>AFFILIATED COMPANY </B>to which <B>LICENSEE </B>has
granted a sublicense of the <B>TECHNOLOGY </B>under this Agreement, but shall not include any service provider of <B>LICENSEE, an AFFILIATED COMPANY or SUBLICENSEE </B>obtaining an implied<B> </B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>license under the <B>TECHNOLOGY </B>to perform the contracted services on behalf of <B>LICENSEE, an AFFILIATED COMPANY or SUBLICENSEE. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.19 <B>&#147;SUBLICENSING INCOME&#148; </B>means everything of value received by <B>LICENSEE </B>in consideration for any sublicense
which includes rights to the <B>TECHNOLOGY </B>licensed herein. For clarity, and subject in all cases to clause (v)&nbsp;below, <B>SUBLICENSING INCOME </B>is the total amount received, regardless of whether or not the <B>SUBLICENSE </B>includes
intellectual property in addition to the licensed <B>TECHNOLOGY, </B>and includes the sublicense fee, milestone payments, stock or other forms of equity, and the fair value of any services or other compensation received. The following may be
excluded from the gross amount received for the sublicense when calculating <B>SUBLICENSING INCOME: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) The reasonable cost of
services to be performed thereafter by <B>LICENSEE </B>or an <B>AFFILIATED COMPANY </B>for or on behalf of the <B>SUBLICENSEE </B>if, but only if, those services are specifically described and the cost itemized and stated separately in the
sublicense. Payments on the achievement of results shall be deemed to be milestone payments and are included in <B>SUBLICENSING INCOME.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) Reimbursement of the amount paid for fees incurred by <B>LICENSEE, </B>such as patent costs, or fees paid to governmental agencies, which
are incurred after the date of the sublicense and are actually paid to third parties by <B>LICENSEE.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) Royalty payments on
<B>SUBLICENSEE&#146;S NET REVENUES, </B>which will be paid to <B>JHU </B>on pursuant to and on the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iv) The
amount of any milestone payment made to <B>JHU </B>under this Agreement as a result of activity of <B>LICENSEE or SUBLICENSEE, </B>which results in a milestone payment by the sublicense to <B>LICENSEE </B>under the <B>SUBLICENSE</B>. The difference
between the milestone payment to be paid to <B>JHU </B>and the milestone payment paid to <B>LICENSEE </B>by the sublicensee shall be considered <B>SUBLICENSING INCOME</B>. For clarification, if <B>SUBLICENSEE </B>makes a payment to <B>LICENSEE
</B>as a milestone, and <B>LICENSEE </B>is obligated to make a milestone payment to <B>JHU </B>under this Agreement for that same milestone, that milestone payment amount paid to <B>JHU </B>shall be deducted from the milestone amount paid under the
<B>SUBLICENSE, </B>and the remainder shall be the <B>SUBLICENSING INCOME.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(v) The amount received for technology independently
developed by <B>LICENSEE </B>or its <B>AFFILIATED COMPANIES, </B>or technology of third parties licensed or acquired by <B>LICENSEE </B>or its <B>AFFILIATED COMPANIES </B>and included in the <B>SUBLICENSE, </B>including <B>LICENSEE&#146;S </B>patent
rights claiming the composition of galeterone and related methods and formulations, if said amount is separately stated in the sublicense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the
<B>SUBLICENSE</B> includes the right or obligation of the <B>SUBLICENSEE</B> to purchase equity in <B>LICENSEE</B> at a cost greater than the then current fair market value of the equity, the difference between the fair market value and the amount
paid shall be <B>SUBLICENSING INCOME.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.20 <B>&#147;TECHNOLOGY&#148;</B> means the <B>LICENSED PATENT(S)</B> and <B>KNOW
HOW</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.21 <B>&#147;VALID CLAIM&#148; </B>means those claims of an issued patent in any country that (i)&nbsp;has not
expired; (ii)&nbsp;has not been disclaimed; (iii)&nbsp;has not been revoked, held invalid, or otherwise declared unenforceable or not allowable by a tribunal or patent authority of competent jurisdiction over such<B>
</B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
</B>claim in such country from which no further appeal has or may be taken; and (iv)&nbsp;in the case of a pending application, was filed and is being prosecuted in good faith towards
allowance.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>GRANT </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.1 <B>Grant</B>. Subject to the terms and conditions of this Agreement,
<B>JHU </B>grants <B>LICENSEE </B>and its <B>AFFILIATED COMPANIES an EXCLUSIVE LICENSE </B>under the <B>LICENSED PATENTS </B>and a non-exclusive license under the <B>KNOW-HOW </B>in the <B>FIELD of USE </B>to make, have made, use, sell, offer to
sell and import <B>LICENSED PRODUCTS </B>and perform <B>LICENSED SERVICES </B>in the <B>LICENSED TERRITORY</B>. If any <B>AFFILIATED COMPANY </B>exercises rights under this Agreement, such <B>AFFILIATED COMPANY </B>shall be bound by all terms and
conditions of this Agreement, including but not limited to indemnity and insurance provisions and royalty payments. In addition, <B>LICENSEE </B>shall remain fully liable to <B>JHU </B>for all acts and obligations of <B>AFFILIATED COMPANY </B>such
that acts of the <B>AFFILIATED COMPANY </B>shall be considered acts of the <B>LICENSEE. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.2 <B>Retained Rights</B>.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.2.1 <B>JHU Rights</B>. JHU retains the right, on behalf of itself, the <B>INVENTORS</B> and all other non-profit academic or
research institutions to whom <B>JHU</B> extends rights, to practice and use <B>TECHNOLOGY</B> in the <B>FIELD OF USE</B> for any research or non-profit purpose, including, but not limited to sponsored research and collaborations with commercial
entities (including for clinical trials), and assessment of patients at JHHS/JHU institutions (such as via the JHU CUA laboratory). <B>JHU</B> also has the right to publish any information included in the <B>TECHNOLOGY.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.2.2 <B>Government Rights</B>. This Agreement is subject to Title 35 Sections 200-204 of the United States Code as implemented in 37 CFR Part
401, as may be amended from time to time. Among other things, these provisions provide the United States Government with certain nonexclusive rights in a <B>LICENSED PATENT</B> if federal funds were used to develop the <B>TECHNOLOGY</B>. They also
impose the obligation that <B>LICENSED PRODUCTS</B> sold or produced in the United States be &#147;manufactured substantially in the United States. <B>LICENSEE</B> will ensure all required obligations of these provisions are met. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.2.3 <B>No Implied licenses</B>. The practice of the foregoing retained rights by <B>JHU</B> shall under no circumstances be construed as a
license or ownership interest in, or other right to, any patent rights, know-how or other intellectual property rights of <B>LICENSEE</B> or its <B>AFFILIATED COMPANIES</B> and <B>SUBLICENSEES,</B> including without limitation any intellectual
property rights covering or claiming galeterone or methods of manufacture or use thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <B>Option Grant</B>. <B>JHU </B>will inform
<B>LICENSEE </B>in writing of <B>IMPROVEMENTS</B>. <B>JHU </B>grants to <B>LICENSEE </B>an option to negotiate for an exclusive license in the <B>FIELD OF USE </B>to any and all of <B>JHU&#146;s </B>interests in the <B>IMPROVEMENTS</B>. The parties
agree to negotiate in good faith the commercially reasonable terms and conditions of such an exclusive license, that may arise out of this Agreement. <B>LICENSEE </B>shall exercise its option by notifying <B>JHU </B>in writing of <B>IMPROVEMENTS
</B>which <B>LICENSEE </B>intends to license within [**] days of <B>LICENSEE&#146;s </B>notification by <B>JHU </B>of such <B>IMPROVEMENTS</B>. <B>LICENSEE </B>shall also provide <B>JHU </B>with a diligence plan providing reasonable assurance to
<B>JHU of LICENSEE&#146;S </B>plans and capabilities to develop <B>IMPROVEMENTS </B>into a <B>LICENSED PRODUCT or LICENSED SERVICE </B>in the <B>FIELD OF USE </B>for public use or benefit. The option will be subject to <B>LICENSEE </B>reimbursing
<B>JHU </B>for all unreimbursed costs of preparation, filing, prosecution and maintenance of patent rights incurred during the option and negotiation periods with respect to any <B>IMPROVEMENTS</B>. <B>JHU </B>and <B>LICENSEE </B>will have [**]
months to come to terms after <B>JHU </B>receives notice of <B>LICENSEE&#146;s </B>intent to license any </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>IMPROVEMENTS, </B>after which, <B>JHU </B>will be free to license such <B>IMPROVEMENTS </B>to third parties without restriction. Such option will be subject to (i)&nbsp;Section&nbsp;2.2 above,
and (ii)&nbsp;any third party rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.4 <B>Specific Exclusions</B>. <B>JHU</B> does not:<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.4.1 commit to <B>LICENSEE</B> to bring suit against third parties for infringement, except as described in Article 9; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.4.2 agree to furnish to <B>LICENSEE</B> any technology or technological information other than the <B>TECHNOLOGY;</B> or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.4.3 agree to provide <B>LICENSEE</B> with any know how, invention, data, results or other assistance in the future unless specifically and
clearly identified in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.5 <B>Transfer of Know-How</B>. Promptly following the <B>EFFECTIVE DATE, JHU, </B>through
the <B>INVENTORS, </B>shall provide <B>LICENSEE </B>with tangible manifestations of the <B>KNOW-HOW </B>in existence as of the <B>EFFECTIVE DATE </B>that may be reasonably requested by <B>LICENSEE, </B>and shall ensure that the <B>INVENTORS </B>will
be reasonably available to <B>LICENSEE </B>during the [**] month period following the <B>EFFECTIVE DATE </B>to respond to questions that <B>LICENSEE </B>may have regarding the use or practice of the <B>KNOW-HOW </B>in the <B>FIELD OF USE. </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>SUBLICENSING </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.1 <B>Permitted Sublicensing</B>. <B>LICENSEE</B> may grant
sublicenses in the <B>FIELD OF USE</B> in the <B>LICENSED TERRITORY</B>. For clarity, <B>LICENSEE</B> shall be responsible to pay <B>JHU</B> royalties due <B>JHU</B> on sales of <B>LICENSED PRODUCTS</B> and <B>LICENSED SERVICES</B> by a
<B>SUBLICENSEE</B>, to the same extent as if <B>LICENSEE</B> made those sales directly, and whether or not <B>SUBLICENSEE</B> remits required royalty payments to <B>LICENSEE</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.2 <B>Sublicense Requirements</B>. Any sublicense agreement executed pursuant to Section 3.1:<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) is subject to this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) will not permit a <B>SUBLICENSEE </B>to further sublicense without <B>JHU&#146;s </B>consent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) will, as a condition of validity, expressly include the provisions of Articles 7, 8, 10.3 and 12.2 for the benefit of <B>JHU;</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iv) will, if this Agreement is terminated, require the transfer to <B>JHU </B>of all obligations, including the payment of royalties
specified in the <B>SUBLICENSE, </B>without setoff for debts or obligations of <B>LICENSEE to SUBLICENSEE; </B>and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(v) will not be valid
against <B>JHU </B>as to terms, conditions, obligations or limitations that are inconsistent with this Agreement and these sublicensing requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.3 <B>Notice and Copy of Sublicense</B>. <B>LICENSEE </B>will notify <B>JHU </B>and within [**] days of execution will submit to
<B>JHU </B>an unredacted copy of each sublicense, the terms of which will not be considered confidential as to <B>JHU, </B>but which terms <B>JHU </B>will treat as <B>LICENSEE&#146;s </B>confidential information.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.4 <B>Sublicensing Income</B>. <B>LICENSEE </B>will share with and pay to <B>JHU </B>that portion of <B>SUBLICENSING INCOME </B>as
stated in <U>Exhibit A</U>.<B> </B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>DILIGENCE REPORTING AND DEVELOPMENT </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4.1 <B>Federal Funding</B>. It is the
requirement of federal law, and the obligation of <B>JHU </B>and <B>LICENSEE, </B>that inventions created with federal funding be diligently developed into useful products and services.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4.2 <B>Milestones</B>. <B>LICENSEE </B>will diligently develop markets for and develop, manufacture, and sell <B>LICENSED PRODUCTS
</B>and <B>LICENSED SERVICES</B>. In addition, <B>LICENSEE </B>will use commercially reasonable efforts to meet the milestones and target dates, if any, shown in Exhibit A, and notify <B>JHU </B>in writing within [**] days after each milestone is
met.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4.3 <B>Diligence Report</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.3.1 By [**] of each year, <B>LICENSEE</B> will submit a written annual report to <B>JHU</B> covering the preceding calendar year. The report
will follow the Diligence Report Guidelines stated on Exhibit C and shall include information reasonably sufficient to enable <B>JHU</B> to satisfy reporting requirements of the U.S. Government and for <B>JHU</B> to ascertain progress by
<B>LICENSEE</B> toward meeting this Agreement&#146;s diligence requirements. Each report will describe, where relevant: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) progress by
<B>LICENSEE</B>, <B>AFFILIATED COMPANIES</B> or <B>SUBLICENSEE(S)</B> toward commercialization of <B>LICENSED PRODUCTS</B> or <B>LICENSED SERVICES</B>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any FDA or other governmental filings and/or approvals regarding any <B>LICENSED PRODUCTS or LICENSED SERVICE</B> made or obtained by
<B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE,</B> the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a certificate of insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not
currently required; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) identification of all <B>AFFILIATED COMPANIES</B> and <B>SUBLICENSEE(S)</B> which have exercised rights to the
<B>TECHNOLOGY,</B> or a statement that no <B>AFFILIATED COMPANY</B> or <B>SUBLICENSEE</B> has exercised such rights; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) description of
any diligence milestones achieved during the prior, and identification of any milestones expected to be achieved in the next year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)
description of any sublicenses under the <B>TECHNOLOGY</B> that were entered during the year, with a copy of the sublicense agreement if not previously provided. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) notification of any change of control, name change or other significant change related to this Agreement or <B></B><B>LICENSEE.</B>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.3.2 Reports may be submitted electronically to an email address provided on request by <B>JHU</B>. Such reports shall be the
Confidential Information of <B>LICENSEE.</B> </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>FEES, ROYALTIES AND OTHER PAYMENTS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.1 <B>License Fee</B>. <B>LICENSEE </B>shall
pay to <B>JHU </B>the noncreditable, nonrefundable license fee as described in <U>Exhibit A</U> within [**] days of the <B>EFFECTIVE DATE. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.2 <B>Patent Costs</B>. <U>Exhibit A</U> includes a summary of unreimbursed <B>PATENT COSTS, </B>and <B>LICENSEE </B>will reimburse
<B>JHU </B>the amount stated in <U>Exhibit A</U> at such time or in such manner as stated in <U>Exhibit A</U>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.3
<B>Minimum Annual Royalty</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5.3.1 <B>LICENSEE</B> will pay <B>JHU</B> a yearly Minimum Annual Royalty <B>(&#147;MAR&#148;)</B>
as described in Exhibit A, which will be paid in advance on or before [**] of each calendar year and which will apply to that calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5.3.2 MAR payments are nonrefundable. Earned royalty payments due on <B>NET REVENUES</B> occurring in the year to which the MAR pertains may
be offset against the Minimum Annual Royalty paid for that year, but only for that year, without carry forward or back. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.4
<B>Milestone Payments</B>. <B>LICENSEE </B>will pay <B>JHU </B>milestone payments as stated on <U>Exhibit A</U>. Within [**] days of achieving a milestone set forth on Exhibit A. <B>LICENSEE </B>will report the achievement to <B>JHU, </B>and pay to
<B>JHU </B>the milestone payment required. Milestones achieved should be included in the diligence report described in Section&nbsp;4.3, even if previously reported.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.5 <B>Earned Royalty</B>. <B>LICENSEE </B>will pay <B>JHU </B>earned royalties, as described in Exhibit A, which shall be paid
quarterly unless a different payment schedule is specifically stated. <B>LICENSEE </B>may deduct from the earned royalty the amount of any MAR paid for the year in which the quarter occurs, until all of the MAR has been deducted from payments due
for that year, after which any earned royalty in excess of the MAR shall be paid to <B>JHU. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.6 <B>Duration of Royalty
Payments</B>. Royalties shall be paid as described in Exhibit A for each <B>LICENSED PRODUCT </B>manufactured or produced or each <B>LICENSED SERVICE </B>performed, on a <FONT STYLE="white-space:nowrap">country-by-</FONT> country basis, until the
later to occur of: (a)&nbsp;ten (10)&nbsp;years from date of <B>FIRST COMMERCIAL SALE </B>of that particular <B>LICENSED PRODUCT or LICENSED SERVICE </B>in that country and (b)&nbsp;the last to expire patent included within the <B>LICENSED PATENTS
</B>in such country.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.7 <B>Payment for All Activities Performed under this Agreement</B>. <B>If LICENSED PRODUCTS </B>are
made, used, imported, or offered for sale before the date this Agreement terminates, and those <B>LICENSED PRODUCTS </B>are sold after the effective date of termination, <B>LICENSEE </B>will pay <B>JHU </B>the earned royalty based on the <B>NET
REVENUE </B>of those <B>LICENSED PRODUCTS</B>. In addition, use of the <B>TECHNOLOGY </B>by <B>LICENSEE </B>shall be deemed to be use which is licensed under this Agreement, regardless of where performed, whether or not specific <B>LICENSED PATENTS
</B>exist in the location of the activity for which activity a royalty or other payment is due under this Agreement.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.8
<B>Obligation to Pay Royalties and Other Payments</B>. Payments required herein must be paid on the dates or upon the conditions stated, notwithstanding any claims by either <B>LICENSEE </B>or third party challenging the validity of the <B>LICENSED
PATENTS</B>. Payments once made are not refundable even if the <B>LICENSED PATENTS </B>are later determined to be invalid or not applicable to the particular product or service.<B> </B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.9 <B>Currency</B>. For <B>NET REVENUES </B>in currencies other than U.S. Dollars,
<B>LICENSEE </B>will calculated the royalty in U.S. Dollars quarterly, using the appropriate foreign exchange rate for the currency as quoted by the United States Federal Reserve Bank, for the last business day of each calendar quarter, to apply to
payments earned by activities during that quarter.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.10 <B>Non-U.S. Taxes</B>. If non-U.S. taxes are due on royalty or
other payments, such taxes shall be deemed to be in addition to the payment, and <B>LICENSEE </B>will pay all non-U.S. taxes related to royalty and any other payments under this Agreement. These tax payments are not deductible from any payments due
to <B>JHU</B>. <B>JHU </B>will cooperate with <B>LICENSEE </B>to receive a refund of such taxes to the extent available, and such refund shall be retained by <B>LICENSEE. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.11 <B>No requirement of invoice</B>. All payments are due on the due date without invoice or demand for payment by or from JHU.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.12 <B>Interest</B>. Payments are considered due on the dates and at the times described in this agreement, and if not so
stated, within [**] days of the date of the event requiring the payment. Payment is made when received by <B>JHU</B>. Payments not received within [**] days of the due date shall, beginning on the due date, bear interest at the rate of [**]% per
annum, whether or not <B>JHU </B>has made a demand for such payment or interest. Acceptance of late payments without interest will not act as a waiver of this provision.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.13 <B>Payments and Obligations</B>. All payments and obligations which come due shall be and remain due, and the existence of a
dispute shall not suspend any duties under this License Agreement.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.14 <B>Invoicing by JHU</B>. <B>JHU </B>may submit all
invoices for any payments due in electronic form via e-mail sent to the e-mail address supplied by <B>LICENSEE </B>from time to time. An invoice directed to the last email address provided by <B>LICENSEE to JHU </B>shall be deemed received by
<B>LICENSEE </B>when sent by <B>JHU. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.15 <B>Method of Payment</B>. All payments under this Agreement shall be made in U.S.
Dollars by either check or wire transfer.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5.16 <B>Payment Information</B>. Payments shall be made as follows, or as further
notified from time to time by <B>JHU: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>All check payments from <B>LICENSEE to JHU </B>shall be sent to:<B> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="7%"></TD> 
<TD VALIGN="bottom" WIDTH="2%"></TD> 
<TD WIDTH="3%"></TD> 
<TD VALIGN="bottom" WIDTH="2%"></TD> 
<TD WIDTH="86%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Attention:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Executive Director</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Johns Hopkins Technology Transfer</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">The Johns Hopkins University</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">100 N. Charles Street</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">5th Floor</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Baltimore, MD 21201</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Attn:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">A26360</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other addresses which JHU may designate in writing from time to time. Checks are to be made payable to the &#147;Johns
Hopkins University&#148;. Wire transfers may be made through: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="7%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="92%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">ACH&nbsp;Info:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">[**]</TD></TR></TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="9%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="90%"></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">FED&nbsp;WIRE:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">[**]</TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">FED&nbsp;WIRE:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">[**]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company shall be responsible for any and all costs associated with wire transfers. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>ROYALTY REPORTS AND ACCOUNTING </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.1 <B>Quarterly Earned Royalty Payment and
Report</B>. Beginning with the <B>FIRST COMMERCIAL SALE </B>of a <B>LICENSED PRODUCT or LICENSED SERVICE, LICENSEE </B>will thereafter submit to <B>JHU </B>a written report [**] days after the end of each calendar quarter (even if there are no
<B>NET REVENUES </B>during that quarter), along with payment of any earned royalty due. This report will be in the form of <U>Exhibit B</U> and will state the number, description, and aggregate <B>NET REVENUES of LICENSED PRODUCTS </B>and
<B>LICENSED SERVICES </B>for the completed calendar quarter. Such reports must be filed and payments made during any claim against or challenge to the scope or validity of the <B>LICENSED PATENTS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.2 <B>No Refund</B>. In the event that a validity or non-infringement challenge of a <B>LICENSED PATENT </B>is successful, <B>LICENSEE
</B>will have no right to recoup any royalties paid before or during the challenge period.<B> </B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.3 <B>Termination or Expiration Report</B>. <B>LICENSEE </B>will pay to <B>JHU </B>all
applicable royalties and submit to <B>JHU </B>a written report within [**] days after the license expires or terminates. <B>LICENSEE </B>will continue to submit required earned royalty payments and reports to <B>JHU </B>after the license terminates,
until all <B>LICENSED PRODUCTS </B>made or imported under the license have been sold, and thereafter until the time for paying earned royalties has expired.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <B>Accounting</B>. <B>LICENSEE </B>will maintain records showing manufacture, importation, sale, and use of <B>LICENSED PRODUCTS </B>or
performance of <B>LICENSED SERVICES </B>and the revenue received for [**] years from the date of sale of that <B>LICENSED PRODUCT or LICENSED SERVICE</B>. Records will include general ledger records showing cash receipts and expenses, and records
that include production records, customers, invoices, serial numbers and related information in sufficient detail to enable <B>JHU </B>to determine the royalties payable under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.5 <B>Audit by JHU</B>. <B>LICENSEE </B>will allow an independent accounting firm designated by <B>JHU </B>to examine
<B>LICENSEE&#146;s </B>records during regular business hours upon [**] days&#146; prior written notice to LICENSEE for the sole purpose of verifying payments made by <B>LICENSEE </B>under this Agreement. Such inspection may not be made more than
[**]. The costs of such inspection shall be paid by JHU; provided, however, that if the audit reveals an underreporting of earned royalties due <B>JHU </B>of more than [**] percent ([**]%) for the period being audited, <B>LICENSEE </B>will pay the
additional royalties due, and reimburse <B>JHU </B>the reasonable audit costs incurred.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>WARRANTIES, EXCLUSIONS AND NEGATION </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.1 <B>JHU Warranty</B>. <B>JHU </B>warrants
and represents that the Inventors listed have provided an invention disclosure to the JHU Office of Technology Transfer <B>(&#147;JHTT&#148;), </B>that the Inventors have assigned such rights as they have in the Inventions to <B>JHU, </B>and that
<B>JHU, </B>as assignee of the Inventions, has filed the patent applications referred to in this Agreement. <B>JHU </B>further warrants and represents that it has the complete right and authority to grant the licenses to <B>LICENSEE </B>hereunder,
and that this Agreement and the exercise by <B>LICENSEE </B>of its rights hereunder does not violate or conflict with an contractual or other right that <B>JHU </B>or its affiliated entities has with a third party. To the best of <B>JHU&#146;s
</B>knowledge, information and belief, the <B>LICENSED PATENT(S) </B>accurately list the inventors of that Patent and <B>JHU </B>has received no claims of a third party to rights in the <B>LICENSED PATENTS </B>other than as may be specifically
stated in this Agreement. <B>JHU </B>does not warrant against presently unknown claims of third parties that may arise after this Agreement.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.2 <B>Negation of Warranties</B>. Except as set forth in Section&nbsp;7.1,<B> JHU</B> provides <B>LICENSEE </B>the rights granted in
this Agreement AS IS and WITH ALL FAULTS. <B>JHU </B>makes no other representations and extends no warranties of any kind, either express or implied. Among other things, <B>JHU </B>disclaims any express or implied warranties of merchantability or
fitness for a particular purpose.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.3 <B>No Representation of LICENSED PATENT</B>. <B>LICENSEE </B>also acknowledges that
<B>JHU </B>does not represent or warrant:<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) the validity or scope of any <B>LICENSED PATENT, </B>or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) that the exploitation of <B>LICENSED PATENT or TECHNOLOGY</B> will be successful, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) except as set forth in Section&nbsp;7.1,that there are no third party claims or prior filed patents that would affect ownership of the
<B>TECHNOLOGY </B>or freedom to operate. </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.4 <B>No other Promises or Warranties</B>. Other than the obligations specifically stated
in this Agreement, <B>JHU </B>makes no promises, express or implied, regarding the <B>TECHNOLOGY</B>. <B>LICENSEE </B>agrees that no representation or statement by any <B>JHU </B>employee shall be deemed to be a statement or representation by
<B>JHU, </B>and that <B>LICENSEE </B>was not induced to enter this Agreement based upon any statement or representation of <B>JHU, </B>or any employee of <B>JHU</B>. <B>JHU </B>is not responsible for any publications, experiments or results reported
by any <B>JHU </B>employee, now or in the future, including any of the <B>INVENTORS </B>and it is the sole responsibility of <B>LICENSEE </B>to evaluate the <B>TECHNOLOGY </B>and the accuracy of any data or results.<B> </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>INDEMNITY AND INSURANCE </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.1 <B>Application</B>. <B>LICENSEE </B>shall have
exclusive control over the <B>LICENSED PRODUCTS </B>and <B>LICENSED SERVICES </B>provided by <B>LICENSEE, </B>and the risks and costs associated therewith. Therefore, LICENSEE will protect JHU INDEMNITEES from exposure to damages which arise from
the actions of LICENSEE.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.2 <B>Indemnification</B>. <B>LICENSEE, AFFILIATED COMPANY </B>and/or <B>SUBLICENSEE </B>agree
that each shall be responsible for injuries or losses to third parties arising from or related to their own acts or omissions, or caused by or arising from <B>LICENSED PRODUCTS or LICENSED SERVICES, </B>or allegedly arising as a consequence of the
exercise by <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE </B>of any rights granted in this Agreement. To that end, <B>LICENSEE, AFFILIATED COMPANY </B>and <B>SUBLICENSEE </B>shall protect <B>JHU INDEMNITEES </B>from any third party claims arising
therefrom, including defending any action brought against <B>JHU INDEMNITEES, </B>with counsel reasonably acceptable to <B>JHU, </B>and indemnifying <B>JHU INDEMNITEES </B>as against any judgments, fees, expenses, or other costs arising from or
incidental to any such lawsuit, claim, demand or other action, whether or not any <B>JHU INDEMNITEE, </B>is named as a party defendant in any such lawsuit and whether or not the <B>JHU INDEMNITEES </B>are alleged to be negligent or otherwise
responsible for any injuries to persons or property. Exercise of the rights granted in this Agreement, by an <B>AFFILIATED COMPANY </B>or an agent or a <B>SUBLICENSEE </B>or a third party on behalf of or for the account of <B>LICENSEE, </B>shall be
considered <B>LICENSEE&#146;s </B>practice of said inventions for purposes of this Paragraph.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.3 <B>Exclusions</B>.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.3.1 No indemnification will be provided for claims arising from the practice by a <B>JHU INDEMNITEE</B> of the <B>LICENSED
PATENTS,</B> or exercise of rights retained by <B>JHU</B> under this Agreement, or the practice of the <B>LICENSED PATENTS</B> outside the <B></B>FIELD OF USE by a third party licensee of <B>JHU.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.3.2 No indemnification will be provided for a claim against a <B>JHU INDEMNITEE</B> for injuries allegedly caused solely and directly by
negligent use or administration by a <B>JHU INDEMNITEE</B> of a <B>LICENSED PRODUCT or LICENSED SERVICE,</B> but any products liability or similar claim based upon a <B>LICENSED PRODUCT or LICENSED SERVICE,</B> made by or provided by <B>LICENSEE</B>
or any <B>AFFILIATED COMPANY or SUBLICENSEE</B> will be covered by this indemnification requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.4 <B>Survival after
Termination</B>. The obligation of <B>LICENSEE </B>to defend and indemnify as set out in this Paragraph shall survive the termination of this Agreement, shall continue even after assignment of rights and responsibilities to an <B>AFFILIATED COMPANY
or SUBLICENSEE, </B>and shall not be limited by any other limitation of liability elsewhere in this Agreement.<B> </B></P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.5 <B>Rights and Obligations of JHU</B>. <B>JHU </B>shall provide <B>LICENSEE </B>with
prompt notice of any claims covered by <B>LICENSEE&#146;s </B>obligation to indemnify, and will provide reasonable cooperation to <B>LICENSEE in LICENSEE&#146;s </B>investigation and defense of such <B></B>claims. <B>JHU </B>shall have the right to
participate in such defense with counsel of its choice and at <B>JHU&#146;s </B>own expense. <B>JHU </B>shall have the right to approve the settlement of any claim hereunder that imposes any liability or obligation on <B>JHU, </B>or affects the
<B>LICENSED PATENTS, </B>other than the payment of money damages paid by the <B>LICENSEE. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.6 <B>Insurance</B>. Prior to
initial human testing or <B>FIRST COMMERCIAL SALE </B>of any <B>LICENSED PRODUCT or LICENSED SERVICE, LICENSEE </B>will establish and maintain Comprehensive General Liability Insurance, including Product Liability Insurance, with a reputable and
financially secure insurance carrier acceptable to <B>JHU </B>to cover any liability of <B>LICENSEE </B>and <B>JHU </B>to third parties related to any <B>LICENSED PRODUCT or LICENSED SERVICE, </B>or otherwise arising from the activities of
<B>LICENSEE, </B>any <B>AFFILIATED COMPANY or SUBLICENSEE</B>. The <B>LICENSEE </B>or the acquired insurance will provide minimum limits of liability of $[**] per claim and $[**] in aggregate and will include all <B>JHU INDEMNITEES </B>as additional
insureds. <B>LICENSEE </B>will furnish a Certificate of Insurance or other evidence of compliance upon reasonable request. All insurance of <B>LICENSEE </B>will be primary coverage; other insurance of <B>JHU </B>and <B>JHU INDEMNITEES </B>will be
excess and noncontributory.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>PATENT PROSECUTION, MAINTENANCE,&nbsp;&amp; INFRINGEMENT </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9.1
<B>Prosecution&nbsp;&amp; Maintenance</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.1.1 <B>Filing and Prosecution</B>. <B>JHU, at LICENSEE&#146;s</B> expense, shall
file, prosecute and maintain all patents and patent applications specified under <B>LICENSED PATENTS</B>. Title to all such patents and patent applications shall reside in <B>JHU</B>. <B>JHU</B> shall have final decision authority over all patent
matter. <B>JHU</B> shall (a)&nbsp;request its patent counsel to timely copy <B>LICENSEE</B> on all official actions and written correspondence with any patent office, and (b)&nbsp;allow <B>LICENSEE</B> an opportunity to comment and advise <B>JHU</B>
on all matters relating to the prosecution and maintenance of the <B>LICENSED PATENTS</B>. <B>JHU</B> will consider any of <B>LICENSEE&#146;s</B> comments and advice in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.1.2 <B>Responsibility of Licensee</B>. <B>LICENSEE</B> shall be responsible for assuring that <B>LICENSED PATENTS</B> desired by
<B>LICENSEE</B> are protected to the extent and in the areas desired by <B>LICENSEE,</B> including assuring timely review of patents drafted or filed, timely filing as necessary and payment of required costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.1.3 <B>Election Not to File in Certain Jurisdictions</B>. By concurrent written notification to <B>JHU</B> and its patent counsel at least
[**] days in advance (or later at <B>JHU&#146;s</B> discretion) of any filing or response deadline, or fee due date, <B>LICENSEE</B> may elect not to have a patent application filed in any particular country or not to pay expenses associated with
prosecuting or maintaining any patent application or patent, provided that <B>LICENSEE</B> pays for all costs incurred up to <B>JHU&#146;s</B> receipt of such notification. Failure to provide such notification will be considered by <B>JHU</B> to be
<B>LICENSEE&#146;s</B> authorization to proceed at <B>LICENSEE&#146;s</B> expense. Upon such notification, <B>JHU</B> may file, prosecute, and/or maintain such patent applications or patent at its own expense and for its own benefit, and any rights
or license granted hereunder held by <B>LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S)</B> relating to the <B>LICENSED PATENTS</B> which comprise the subject of such patent applications or patent and/or apply to the particular country, shall
terminate, and thereafter reside solely in <B>JHU.</B> </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <B>Notification of Infringement by Third Party</B>.<B></B> Each party will notify the other
promptly in writing when any infringement by another is uncovered or suspected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <B>Suit for Infringement</B>.<B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.3.1 <B>LICENSEE</B> shall have the first right to enforce the <B>LICENSED PATENTS</B> in the <B>FIELD OF USE</B> against any infringement or
alleged infringement thereof, and shall at all times keep <B>JHU</B> informed as to the status thereof. This right to sue for infringement shall not be used in an arbitrary or capricious manner. Before <B>LICENSEE</B> commences an action with
respect to any infringement of such patents, <B>LICENSEE</B> shall give careful consideration to the views of <B>JHU</B> and to potential effects on the public interest in making its decision whether or not to sue. Thereafter, <B>LICENSEE</B> may,
at its own expense, institute suit against any such infringer or alleged infringer and control and defend such suit in a manner consistent with the terms and provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.3.2 No settlement, consent judgment or other voluntary final disposition of the suit may be concluded without the prior written consent of
<B>JHU</B>, which consent shall not be unreasonably withheld or delayed. <B>JHU</B> shall reasonably cooperate in any such litigation at <B>LICENSEE&#146;s</B> expense, including being named as a party plaintiff in such action to the extent
required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.3.3 If <B>LICENSEE</B> elects not to enforce any patent within the <B>LICENSED PATENTS</B>, it shall so notify <B>JHU</B>
promptly in writing and <B>JHU</B> may, in its sole judgment and at its own expense, take steps to enforce any patent and control, settle, and defend such suit in a manner consistent with the terms and provisions hereof, and recover, for its own
account, any damages, awards or settlements resulting therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <B>Patent Invalidity Suit</B>. <B>LICENSEE</B> shall defend at
<B>LICENSEE&#146;s</B> expense a declaratory judgment or other action brought by a third party naming <B>LICENSEE or JHU</B> as a defendant and alleging invalidity of any of the <B>LICENSED PATENTS</B>.<B> JHU</B> in its discretion may elect to take
over the sole defense of the action at its own expense, in which case <B>LICENSEE</B> shall cooperate fully with <B>JHU</B> in connection with any such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <B>Recovery. LICENSEE</B> shall pay to <B>JHU</B> [**] percent ([**]%) of any monetary award, settlement or recovery, net of all
reasonable attorneys&#146; fees and out-of-pocket costs and expenses incurred by <B>LICENSEE</B> in connection with each suit or settlement. If the cost and expenses exceed the recovery no additional amount shall be paid to <B>JHU.</B> </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>HANDLING AND RESOLUTION OF DISPUTES. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <B>Governing Law</B>.<B></B> This Agreement
shall be construed, and legal relations between the parties hereto shall be determined, in accordance with the laws of the State of Maryland applicable to contracts executed and wholly to be performed within the State of Maryland without giving
effect to the principles of conflicts of laws. Any disputes between the parties to the Agreement including the applicability or validity of any <B>LICENSED PATENTS</B> may be brought in the state or federal courts located in Baltimore, Maryland.
Both parties agree to waive their right to a jury trial and to consent to jurisdiction in such courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2 <B>Resolution</B>.<B></B> The
parties shall attempt to resolve all disputes through informal means. This may include mediation, arbitration, or any other procedures upon which the parties agree. Each </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
party agrees that, prior to resorting to litigation, it will confer with other party to determine whether other procedures that are less expensive or less time consuming can be adopted to resolve
the dispute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <B>Challenges to LICENSED PATENTS, Scope and Applicability &#150; Requirements During and After Challenge of LICENSED
PATENTS by LICENSEE</B>.<B></B> The provisions of this Paragraph 10.3 shall be included in any <B>SUBLICENSE</B> and pertain also to actions by a <B>SUBLICENSEE</B>. If <B>LICENSEE</B>, Affiliate or <B>SUBLICENSEE </B>brings an action against
<B>JHU</B> challenging the validity or scope of the <B>LICENSED PATENTS,</B> or applicability of the <B>LICENSED PATENTS</B> to a <B>LICENSED PRODUCT</B> or <B>LICENSED SERVICE</B> the following shall apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.1 Actions by a <B>SUBLICENSEE</B> shall be attributed to <B>LICENSEE</B> unless <B>LICENSEE</B> demonstrates that the action was taken
independent of any influence by <B>LICENSEE</B>, and <B>LICENSEE</B> fully cooperates in defending the action, including affirming the validity of the <B>LICENSED PATENTS</B> challenged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.2 If such action determines that at least one claim of a patent challenged by <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE</B> is valid
and, if applicable, but for this Agreement, infringed by a <B>LICENSED PRODUCT or LICENSED SERVICE,</B> the party challenging will thereafter, except as to <B>PATENT COSTS,</B> [**]. For clarity, this shall apply to [**], except incurred <B>PATENT
COSTS</B> which will be paid as otherwise agreed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.3 If such action determines that at least one claim of a patent challenged by
<B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE</B> is valid and, if applicable, but for this Agreement, infringed by a <B>LICENSED PRODUCT or LICENSED SERVICE,</B> the <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE</B> challenging will [**]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.4 During the course of such challenge, all payments otherwise required by this Agreement shall be paid as and when due, to the same
extent as if there were no challenge to the <B>LICENSED PATENTS,</B> and <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE</B> will have no right to recoup any payments, including royalties, which become due before or during the challenge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.5 <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE</B> shall not pay royalties into any escrow or other similar account, but shall make all
payments to <B>JHU</B> as due and when due, unless <B>LICENSEE or SUBLICENSEE</B> has prior to the payment becoming due, voluntarily and completely terminated this Agreement. Timely and complete payment and full compliance by <B>LICENSEE,
</B>Affiliate and <B>SUBLICENSEE</B> with all terms of this Agreement shall be a condition precedent to bringing and maintaining the legal action challenging the <B>LICENSED PATENTS.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.3.6 No less than [**] months prior to bringing an action seeking to invalidate or limit a LICENSED PATENT, LICENSEE or AFFILIATED COMPANY
will provide written notice of the expected challenge to JHU which shall include a clear statement of the factual and legal basis for the challenge, and an identification of all prior art and other matter believed to invalidate any claim on the
LICENSED PATENTS or which supports the claim that the LICENSED PATENT does not apply to the LICENSED PRODUCT or LICENSED SERVICE. </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>TERM AND TERMINATION </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1 <B>Term.</B> The term of this Agreement shall commence on the
<B>EFFECTIVE DATE</B> and shall continue, in each country, until the date of expiration of the last to expire patent included within <B>LICENSED PATENTS</B> in that country or if no patents issue then for a term of ten (10)&nbsp;years from the
<B>FIRST COMMERCIAL SALE</B> in such country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <B>Termination by Licensee</B>. LICENSEE may terminate this Agreement by giving
<B>JHU</B> written notice at least 90 days in advance of the proposed effective date of termination selected by <B>LICENSEE</B>. <B>LICENSEE</B> shall pay all sums due under this Agreement, including MARs, earned royalties, milestone payments or
<B>PATENT COSTS</B> which are incurred or are or become due prior to the effective date of termination. In addition, <B>LICENSEE</B> shall also be obligated to pay any <B>PATENT COSTS</B> which are required to be incurred to preserve the patent
prior to the effective date of termination. Termination will not preclude JHU from enforcing its right to collect from LICENSEE amounts accrued and payable prior to the effective date of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 <B>Termination by JHU</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">11.3.1 <B>JHU</B> may terminate this Agreement if <B>LICENSEE</B> fails to perform or otherwise materially breaches any of its material
obligations hereunder, or of any related agreement including a sponsored research agreement if, following the giving of notice by JHU of its intent to terminate and stating the grounds therefor, LICENSEE has not cured the failure or breach within
[**] days. If <B>LICENSEE</B> is diligently and in good faith attempting to cure the default, <B>LICENSEE</B> may request, and <B>JHU</B> shall grant an additional [**] days to cure the default. JHU may also terminate this Agreement if LICENSEE
voluntarily or involuntarily enters bankruptcy or receivership proceedings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">11.3.2 <B>Failure to Meet a Required Diligence
Milestone</B>.<B></B> If this Agreement provides for diligence milestones which must be accomplished by specified dates or within specified periods of time, <B>LICENSEE</B> may cure any default for failure to meet a required diligence milestone in
accordance with this subsection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <B>LICENSEE</B> must be diligently pursuing the milestone and provides <B>JHU</B> a reasonable
explanation of the reasons for such failure and (b)&nbsp;a reasonable, detailed, written plan for promptly achieving a reasonable extended and/or amended milestone. If <B>LICENSEE</B> so notifies <B>JHU</B> and provides <B>JHU</B> with the foregoing
explanation and plan, both of which are acceptable to <B>JHU</B> in its reasonable discretion, then the applicable diligence milestone will be amended in writing to incorporate the extended and/or amended milestone set forth in the plan presented by
<B>LICENSEE.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <B>JHU</B> may not withhold its approval to any extended and/or amended milestone if the explanation provided by
<B>LICENSEE</B> demonstrates to JHU&#146;s reasonable satisfaction that (A)&nbsp;the existence of technical difficulties or delays in preclinical or clinical studies <I>( e.g., </I>negative toxicological or pharmacological test results or an adverse
clinical event) or regulatory processes that <B>LICENSEE,</B> its <B>AFFILIATED COMPANIES</B> and/or <B>SUBLICENSEES</B> could not have reasonably avoided; (B)&nbsp;the issuance of an injunction or the grant of other equitable relief by a court of
competent jurisdiction preventing <B>LICENSEE,</B> its <B>AFFILIATED COMPANIES</B> and/or SUBLICENSEES from practicing an invention under the <B>LICENSED PATENTS;</B> or (C)&nbsp;a failure to achieve, or a material delay in achieving, marketing
approval for galeterone, a <B>LICENSED PRODUCT or LICENSED SERVICE.</B> </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) If the explanation and plan provided by LICENSEE are not reasonably acceptable to
<B>JHU,</B> then <B>LICENSEE</B> may extend the milestone for up to an additional [**] months by paying [**] of the milestone payment associated with the milestone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4 <B>Survival of Sublicenses.</B> Upon termination of this Agreement for any reason, any <B>SUBLICENSEE</B> shall become a direct licensee
of <B>JHU</B> under the terms of this Agreement, provided that <B>JHU&#146;s</B> obligations to <B>SUBLICENSEE(S)</B> are no greater than <B>JHU&#146;s </B>obligations to <B>LICENSEE</B> hereunder. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>MISCELLANEOUS PROVISIONS. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <B>Confidentiality</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.1.1 As used in this Agreement, the term <B>&#147;Confidential Information&#148;</B> means any technical or business information furnished by
<B>LICENSEE</B> to JHTI in connection with this Agreement which is (a)&nbsp;disclosed in writing or other tangible form and is labeled or identified as &#147;CONFIDENTIAL&#148; at the time of disclosure or, by written notice to <B>JHU,</B> within
[**] days following disclosure; (b)&nbsp;disclosed verbally and reduced to writing or other tangible form and similarly labeled, within [**] days of verbal disclosure. It is understood and agreed that reports provided to <B>JHU</B> pursuant to
paragraphs 4.3 and 6.1are Confidential Information hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.1.2 <B>JHU </B>shall and shall cause its employees, faculty, staff,
students, trustees and advisors engaged in the performance of this Agreement to: (a)&nbsp;employ all reasonable and diligent efforts to maintain all Confidential Information in strict confidence, except that <B>JHU </B>may disclose or permit the
disclosure of any Confidential Information to its employees who are obligated to maintain the confidential nature of such Confidential Information and who need to know such Confidential Information to perform this Agreement; (b)&nbsp;use all
Confidential Information solely for purposes of performing this Agreement; and (c)&nbsp;reproduce the Confidential Information only to the extent necessary to perform this Agreement, with all such reproductions being considered Confidential
Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.1.3 The obligations of <B>JHU </B>under Paragraph 12.1.2 shall not apply to Confidential Information to the extent that
<B>JHU </B>can demonstrate that such applicable Confidential Information: (a)&nbsp;was in the public domain prior to the time of its disclosure under this Agreement; (b)&nbsp;entered the public domain after the time of its disclosure under this
Agreement through means other than an unauthorized disclosure resulting from an act or omission by <B>JHU;</B> (c)&nbsp;is or was disclosed to <B>JHU</B> at any time, whether prior to or after the time of its disclosure under this Agreement, by a
third party having no fiduciary obligation of confidentiality with respect to such Confidential Information; (d)&nbsp;is or was developed by or for <B>JHU</B> without reference to information provided by <B>LICENSEE</B> or (e)&nbsp;is required to be
disclosed to comply with applicable laws or regulations, or with a court or administrative order, provided that <B>LICENSEE</B> receives prior written notice of such disclosure and the opportunity to assess the need to disclose and/or limit the
scope of disclosure, and that <B>JHU</B> takes all reasonable and lawful actions at <B>LICENSEE&#146;s</B> request and expense to obtain confidential treatment for such disclosure and, if possible, to minimize the extent of such disclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <B>Patent Marking. LICENSEE</B> agrees that all <B>LICENSED PRODUCT(S)</B> sold by <B>LICENSEE, AFFILIATED COMPANIES</B> and
<B>SUBLICENSEE(S)</B> will be marked with the number of the applicable patent(s) licensed hereunder in accordance with, and to the extent required by, each country&#146;s patent laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3 <B>Use of Name</B>. <B>LICENSEE, AFFILIATED COMPANIES </B>and <B>SUBLICENSEE(S) </B>shall not use the name of The Johns Hopkins
University or The Johns Hopkins Health System or any of its constituent parts, such as the Johns Hopkins Hospital, Johns Hopkins Medicine or any contraction thereof or the name of </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Inventors in any advertising, promotional literature, web sites, electronic media applications, sales literature, fundraising documents, or press releases and other print or electronic
communications without prior written consent from an authorized representative of <B>JHU</B>. <B>LICENSEE, AFFILIATED COMPANIES </B>and <B>SUBLICENSEE(S) </B>shall allow at least [**] business days&#146; notice of any proposed public disclosure for
<B>JHU&#146;s </B>review and comment or to provide written consent, unless a shorter period is required in order for <B>LICENSEE </B>to comply with its disclosure obligations under federal and state securities laws. Such request shall be made
through JHTI. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.4 <B>No Partnership</B>.<B></B> Nothing in this Agreement shall be construed to create any agency, employment,
partnership, joint venture or similar relationship between the parties other than that of a licensor/licensee. Neither party shall have any right or authority whatsoever to incur any liability or obligation (express or implied) or otherwise act in
any manner in the name or on the behalf of the other, or to make any promise, warranty or representation binding on the other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.5
<B>Notice of Claim</B>.<B></B> Each party shall give the other or its representative immediate notice of any suit or action filed, or prompt notice of any claim made, against them arising out of the performance of this Agreement or arising out of
the practice of the inventions licensed hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.6 <B>Assignment.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.6.1 <B>Permitted Assignment by Licensee</B>.<B> LICENSEE</B> may assign this Agreement as part of a sale or merger, regardless of whether
such a sale occurs through an asset sale, stock sale, merger or other combination, if the sale or merger is of <B>LICENSEE&#146;s</B> entire business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.6.2 <B>Any Other Assignment by Licensee</B>.<B></B> Any other attempt to assign this Agreement by <B>LICENSEE</B> is null and void in the
absence of <B>JHU&#146;s</B> written permission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.6.3 <B>Conditions of Assignment</B>.<B></B> For any assignment, the following
conditions must be met: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <B>LICENSEE</B> must give <B>JHU</B> written notice of the assignment once complete, including the new
assignee&#146;s contact information; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the new assignee must agree in writing to <B>JHU </B>to be bound by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.6.4 <B>Assignment Payment to JHU</B>.<B></B> Where the assignment is the result of complete sale or merger of LICENSEE, then
<B>LICENSEE</B> (or its assignee) shall pay to <B>JHU</B> an assignment fee set forth in <U>Exhibit A</U>. For all other assignments, the assignment shall be treated in the same manner as a sublicense, such that assignment income shall be treated as
<B>SUBLICENSING INCOME</B><B>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.6.5 <B>After the Assignment</B>. Upon a permitted complete assignment of this Agreement,
<B>LICENSEE</B> will be released from further obligations under this Agreement, except for those sections that survive termination, and the term <B>&#147;LICENSEE&#148;</B> in this Agreement will thereafter mean the assignee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.7 <B>Notice</B>. Except for those communications which specifically under this Agreement may be sent via e-mail or other electronic
communication (such as notification of <B>PATENT COSTS</B> incurred and due, and other routine communications), all notices, requests or communication required or permitted to be given by either party hereunder shall be given by registered mail or
certified mail, return receipt </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requested, or sent by overnight courier, such as Federal Express, to the other party at its respective address set forth below or to such other address as one party shall give notice of to the
other from time to time hereunder. Notices shall be deemed effective when received. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="13%"></TD> 
<TD VALIGN="bottom" WIDTH="3%"></TD> 
<TD WIDTH="3%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="78%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">If&nbsp;to&nbsp;<B>LICENSEE:</B></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">One Broadway, 14th Floor</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Cambridge, MA 02142</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Attn:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Chief Operating Officer</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">jmcbride@tokaipharma.com</TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="4"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">If to <B>JHU:</B></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Executive Director</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Johns Hopkins Technology Transfer</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">100 N. Charles Street, 5th Floor</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Baltimore, MD 21201</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">RE:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Agreement No. A26360</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Communications requiring a prompt response should also be sent via email to [**] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.8 <B>Compliance with All Laws</B>. In all activities undertaken pursuant to this Agreement, both <B>JHU</B> and <B>LICENSEE</B> covenant
and agree that each will in all material respects comply with such Federal, state and local laws and statutes, as may be in effect at the time of performance and all valid rules, regulations and orders thereof regulating such activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.9 <B>Successors and Assigns</B>. Other than as specifically stated herein, neither this Agreement nor any of the rights or obligations
created herein, except for the right to receive any remuneration hereunder, may be assigned by either party, in whole or in part, without the prior written consent of the other party. This Agreement shall bind and inure to the benefit of the
successors and permitted assigns of the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.10 <B>No Waivers; Severability</B>. No waiver of any breach of this Agreement
shall constitute a waiver of any other breach of the same or other provision of this Agreement, and no waiver shall be effective unless made in writing and signed by the party waiving. Any provision hereof prohibited by or unenforceable under any
applicable law of any jurisdiction shall as to such jurisdiction be deemed ineffective and deleted herefrom without affecting any other provision of this Agreement. It is the desire of the parties hereto that this Agreement be enforced to the
maximum extent permitted by law, and should any provision contained herein be held by any governmental agency or court of competent jurisdiction to be void, illegal and unenforceable, the parties shall negotiate in good faith for a substitute term
or provision which carries out the original intent of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.11 <B>Entire Agreement; Amendment</B>.<B> LICENSEE</B> and
<B>JHU</B> acknowledge that they have read this entire Agreement and that this Agreement, including the attached Exhibits constitutes the entire understanding and contract between the parties hereto and supersedes any and all prior or
contemporaneous oral or written communications with respect to the subject matter hereof, all of which communications are merged herein. It is expressly understood and agreed that: (i)&nbsp;there being no expectations to the contrary between the
parties hereto, no usage of trade, verbal agreement or another regular practice or method dealing within any industry or between the parties hereto shall be used to modify, interpret, supplement or alter in any manner the express terms of this
Agreement; and (ii)&nbsp;this Agreement shall not be modified, amended or in any way altered except by an instrument in writing signed by both of the parties hereto. </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.12 <B>Binding Agreement</B>. Exchange of this Agreement in draft or final form between the
parties shall not be considered a binding offer, and this Agreement shall not be deemed final or binding on either party until the final Agreement has been signed by both parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.13 <B>Delays or Omissions</B>. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to
any party hereto, shall impair any such right, power or remedy to such party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or in any similar breach or default be deemed a waiver of any other
breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions
or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not
alternative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.14 <B>Survival</B>. All representations, warranties, covenants and agreements made herein and which by their express
terms or by implication are to be performed or continue to apply after the execution and/or termination hereof, or are prospective in nature, shall survive such execution and/or termination, as the case may be. In addition, the following shall
explicitly and specifically survive any termination or expiration: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) <B>LICENSEE&#146;s </B>obligation to make payments to <B>JHU,
</B>accrued or accruable during the License, including earned royalties, sublicensing payments, reimbursement of <B>PATENT COSTS, </B>late payments and interest; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) any claim of <B>LICENSEE or JHU, </B>accrued or to accrue, because of any breach or default by the other party; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) the provisions of Articles 7, 8 and Paragraphs 11.4, 12.1 and 12.13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.15 <B>No Third Party Beneficiaries</B>. Nothing in this Agreement shall be construed as giving any person, firm, corporation or other
entity, other than the parties hereto and their successors and permitted assigns, any right, remedy or claim under or in respect of this Agreement or any provision hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.16 <B>Headings</B>. Article headings are for convenient reference and not a part of this Agreement. All Exhibits are incorporated herein by
this reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.17 <B>Counterparts</B>. This Agreement may be executed in counterparts, each of which shall be deemed an original and
all of which when taken together shall be deemed but one instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[signature page follows] </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Agreement shall take effect as of the <B>EFFECTIVE DATE</B> when it has
been executed below by the duly authorized representatives of the parties. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">

 
<TR> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="40%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="39%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="5">THE JOHNS HOPKINS UNIVERSITY</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">TOKAI PHARMACEUTICALS, INC.</TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="16" COLSPAN="5"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="4"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jill E. Uhl</P></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John McBride</P></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Jill E. Uhl</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">John McBride</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">Interim Executive Director</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">COO</TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Date:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3">9 Jan 2015</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">Date:</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">December 23, 2014</TD></TR>
</TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LICENSE DEAL SHEET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PATENTS, FEES, ROYALTIES, SUBLICENSING PAYMENTS AND OTHER TERMS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SPECIFIC TO THE LICENSE </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>INVENTIONS and INVENTORS</B>:<B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[**]. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Unreimbursed Patent Costs:</B> Estimated to be $[**]. Exact amount will be calculated and billed after execution of this Agreement. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>LICENSEE</B> will reimburse half of the unreimbursed <B>PATENT COSTS</B> within [**] days of the <B>EFFECTIVE DATE</B>. The remainder of
unreimbursed <B>PATENT COSTS</B> shall be paid in [**] equal quarterly installments until fully paid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If <B>JHU</B> grants additional
commercial licenses under the <B>LICENSED PATENTS</B> outside the <B>FIELD OF USE</B> for consideration after the <B>EFFECTIVE DATE,</B> <B>JHU</B> shall notify <B>LICENSEE</B> thereof in writing and, from and after the effective date of any such
license, <B>LICENSEE&#146;s</B> obligation to reimburse <B>JHU</B> for any <B>PATENT COSTS</B> shall be reduced on a <I>pro rata </I>basis based on the number of additional commercial licensees of <B>JHU</B>. Any <B>PATENT COSTS</B> paid to
<B>JHU</B> prior to the effective date of any such commercial license will be credited against future payments to <B>JHU,</B> if any such future payments to <B>JHU</B> are pending, on a pro rata basis. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Field of Use:</B> companion diagnostic for Galeterone (excluding commercial sale as research reagent). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Major Market:</B> U.S., France, Germany, Italy, Spain, U.K., Japan, Canada </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>License Fee:</B> The license fee due under Paragraph 5.1 is seventy-five thousand dollars ($75,000). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Minimum Annual Royalties:</B> The MARs described under Paragraph 5.3 are: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%">&nbsp;</TD> 
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD> 
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD> 
<TD ALIGN="left" VALIGN="top">[**] </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%">&nbsp;</TD> 
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD> 
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD> 
<TD ALIGN="left" VALIGN="top">[**] </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="8%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD> 
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD> 
<TD ALIGN="left" VALIGN="top">[**] </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="8%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD> 
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD> 
<TD ALIGN="left" VALIGN="top">[**] </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="8%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD> 
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD> 
<TD ALIGN="left" VALIGN="top">$30,000 [**] </TD></TR></TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Royalties:</B> The earned royalty rate payable under Paragraph 5.5 is [**] percent ([**]%) of <B>NET REVENUE.</B> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Should <B>LICENSEE</B>, any <B>AFFILIATED COMPANY or SUBLICENSEE</B> be required to pay running royalties to a third party in order to make,
have made, use, sell, offer for sale or import a particular <B>LICENSED PRODUCT or LICENSED SERVICE</B> (an <B>&#147;Other Royalty</B><B>&#148;</B>), then <B>LICENSEE</B> shall be entitled to credit [**] percent ([**]%) of such Other Royalties
against the running royalty due to <B>JHU,</B> provided that the running royalties shall not be reduced below [**] percent ([**]%) of those that would otherwise be due <B>JHU</B> for that <B>LICENSED PRODUCT or LICENSED SERVICE.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the earned royalty rate under Paragraph 5.5 shall be [**] percent ([**]%) of <B>NET REVENUE</B> in any country
for any <B>LICENSED PRODUCT and LICENSED SERVICE</B> not covered by an issued patent within <B>LICENSED PATENTS</B> in the country of sale. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Milestone Payments</B>. The milestone payments under Paragraph 5.4 are as follows: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">[**]
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Diligence Milestones</B>. The following milestones shall be achieved no later than the date shown. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>[**]</B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B></B>Sublicensing Income. LICENSEE shall pay to JHU twenty percent (20%)&nbsp;of all SUBLICENSING INCOME. </TD></TR></TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Where multiple technologies or licenses are included on one <B>SUBLICENSE, </B>where the amount
attributed to each is not specifically stated in the <B>SUBLICENSE, </B>the amount attributable to each shall be deemed to apply equally to each technology or license that is included in the <B>SUBLICENSE</B>. Where reasonable to do so, <B>LICENSEE
</B>may request another application of the <B>SUBLICENSING INCOME, </B>by providing a written request and analysis to JHTI of the basis for <B>LICENSEE&#146;s </B>request, but in no circumstance shall less than [**]% of the <B>SUBLICENSING INCOME
</B>be applied to the <B>TECHNOLOGY </B>licensed by this Agreement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD> 
<TD ALIGN="left" VALIGN="top"><B>Assignment Payment to JHU</B>. If an assignment of this Agreement under Section&nbsp;12.6.4 is the result of complete sale or merger of <B>LICENSEE,</B> then <B>LICENSEE </B>(or its assignee) shall pay to JHU an
assignment fee equal to the greater of: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[**]. </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUARTERLY SALES&nbsp;&amp; ROYALTY REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR LICENSE AGREEMENT BETWEEN </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE JOHNS HOPKINS UNIVERSITY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="5%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="41%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="3%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="2%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="40%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" NOWRAP>JHU&nbsp;Reference&nbsp;Number(s)</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8" COLSPAN="3"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="3">PERIOD:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">To</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8" COLSPAN="5"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="5">TOTAL ROYALTIES DUE FOR THIS PERIOD $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD> 
<TD VALIGN="bottom" WIDTH="14%"></TD> 
<TD></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:8pt"> 
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PRODUCT</B><br><B>ID</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PRODUCT</B><br><B>NAME</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>*JHU</B><br><B>REFERENCE</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1st</B><br><B>COMMERCIAL</B><br><B>SALE</B><br><B>DATE</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL</B><br><B>NET</B><br><B>SALES/<BR>SERVICES</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ROYALTY</B><br><B>RATE</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B><br><B>DUE</B></TD></TR>

 
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD></TR> 
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD> 
<TD ALIGN="left" VALIGN="top">Please provide the JHU Reference Number or Patent Reference </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report format is to be used to report
quarterly royalty statements to <B>JHU</B>. It should be placed on <B>LICENSEE</B> letterhead and accompany any royalty payments due for the reporting period. After the first sale on which royalties accrue, this report shall be submitted even if no
sales are reported. </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P> 
 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DILIGENCE AND ANNUAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPORT GUIDELINES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR
LICENSE AGREEMENT BETWEEN </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE JOHNS HOPKINS
UNIVERSITY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

 
<TR> 
<TD WIDTH="5%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="41%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="3%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="2%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="40%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" NOWRAP>JHU&nbsp;Reference&nbsp;Number(s)</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8" COLSPAN="3"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="3">PERIOD:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top">To</TD> 
<TD VALIGN="bottom"></TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A. Progress by <B>LICENSEE, AFFILIATED COMPANIES</B> or <B>SUBLICENSEE(S)</B> toward commercialization of <B>LICENSED
</B><B>PRODUCTS</B> or <B>LICENSED SERVICES</B>: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B. Notice of all FDA or other governmental filings and/or approvals regarding any <B>LICENSED
PRODUCT</B> or <B>LICENSED SERVICE</B> made or obtained by <B>LICENSEE, AFFILIATED COMPANY or SUBLICENSEE,</B> the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of
such product or service: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C. A Certificate of Insurance or other evidence of insurance </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is required and is attached. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; is not required. Reason:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">D. <B>AFFILIATED COMPANIES</B> and <B>SUBLICENSEES</B> which have exercised rights to the <B>TECHNOLOGY</B>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NONE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; List attached with description of rights exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">E. Diligence and other milestones achieved: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">F. Diligence and
other milestones expected to be achieved this year: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">G. Sublicense(s) entered during the year: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NONE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Identification of <B>SUBLICENSEE&#146;s</B> (copy of the <B>SUBLICENSE</B> attached, if not previously provided) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">H. Change of control, name change or other significant change related to this Agreement or <B>LICENSEE:</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NONE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Details: </P> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P> 
 
</BODY></HTML>
</TEXT>
</DOCUMENT>
